ShareValue scores for CARL: Valuation 47, Quality 53, Growth 58, Health 45.
CARLNASDAQ
Carlsmed, Inc. Common Stock
$13.70
(+1.03%)
CARLNASDAQ
Carlsmed, Inc. Common Stock
Verdicts
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
Rating
Trap Risk
Return
Company Details
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.